Stock listing
NASDAQ:ZURA Zura Bio Limited Stock
Home listing (NASDAQ) of Zura Bio Limited
Follow Zura Bio Limited into a list and get an email when it puts out news.
Share price · NASDAQ:ZURA
$0.965 USD -0.070 (-6.8%)
Close on Nov 18, 2026
- Day range
- $0.945 – $1.045 USDNov 18, 2026
- Volume
- 3.02M sharesNov 18, 2026
- Market cap
- $92.96M USDAt the close on Nov 18, 2026 · price × 96.33M shares outstanding
- 52-week range
- $0.934 – $7.440 USDLowest and highest trades, Nov 19, 2025 – Nov 18, 2026
- Traded on an average day
- $13.84M USDMedian day 2.64M shares · last 3 months, Aug 18, 2026 – Nov 18, 2026

Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| NASDAQ:ZURA · Home | $0.965 USD | -0.070 (-6.8%) | 3,023,431 | $1.010 | $1.045 | $0.945 | $1.035 | Close on Nov 18, 2026 |
| Frankfurt:94E | €0.965 EUR | -0.135 (-12.3%) | 5,380 | €0.965 | €0.965 | €0.965 | €1.100 | Close on Nov 17, 2026 |
Daily closes
Last 3 months, Aug 18, 2026 – Nov 18, 2026 · NASDAQ:ZURA · USD, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| $0.965 | -0.070 | -6.8% | $1.010 | $1.045 | $0.945 | 3,023,431 | |
| $1.035 | -0.045 | -4.2% | $1.050 | $1.070 | $0.983 | 3,521,789 | |
| $1.080 | -0.160 | -12.9% | $1.240 | $1.250 | $1.050 | 3,734,049 | |
| $1.240 | 0.000 | 0.0% | $1.230 | $1.250 | $1.130 | 4,239,089 | |
| $1.240 | -0.190 | -13.3% | $1.410 | $1.440 | $1.210 | 3,522,988 | |
| $1.430 | +0.025 | +1.8% | $1.405 | $1.575 | $1.350 | 6,940,510 | |
| $1.405 | +0.165 | +13.3% | $1.170 | $1.530 | $1.163 | 16,982,987 | |
| $1.240 | -2.850 | -69.7% | $1.270 | $1.270 | $0.934 | 64,340,588 | |
| $4.090 | +0.370 | +9.9% | $3.800 | $4.245 | $3.760 | 3,002,600 | |
| $3.720 | -0.300 | -7.5% | $4.000 | $4.010 | $3.700 | 2,655,000 | |
| $4.020 | +0.030 | +0.8% | $4.120 | $4.200 | $3.832 | 1,947,400 | |
| $3.990 | +0.050 | +1.3% | $3.990 | $4.130 | $3.900 | 1,930,200 | |
| $3.940 | -0.100 | -2.5% | $4.040 | $4.140 | $3.865 | 3,721,900 | |
| $4.040 | +0.190 | +4.9% | $3.810 | $4.060 | $3.655 | 4,074,200 | |
| $3.850 | -0.500 | -11.5% | $4.350 | $4.490 | $3.800 | 3,354,900 | |
| $4.350 | +0.080 | +1.9% | $4.230 | $4.600 | $4.110 | 4,389,400 | |
| $4.270 | +0.710 | +19.9% | $3.570 | $4.330 | $3.412 | 5,089,300 | |
| $3.560 | +0.200 | +6.0% | $3.350 | $3.800 | $3.345 | 4,294,900 | |
| $3.360 | -0.170 | -4.8% | $3.540 | $3.595 | $3.270 | 5,820,000 | |
| $3.530 | -0.600 | -14.5% | $4.380 | $4.470 | $3.500 | 8,812,100 | |
| $4.130 | +0.130 | +3.2% | $4.050 | $4.235 | $3.960 | 4,187,900 | |
| $4.000 | +0.190 | +5.0% | $3.830 | $4.210 | $3.810 | 3,317,600 | |
| $3.810 | -0.070 | -1.8% | $3.910 | $4.060 | $3.770 | 4,557,200 | |
| $3.880 | -0.400 | -9.3% | $4.300 | $4.350 | $3.860 | 4,899,700 | |
| $4.280 | -0.130 | -2.9% | $4.420 | $4.500 | $4.150 | 4,991,700 | |
| $4.410 | +0.180 | +4.3% | $4.230 | $4.615 | $4.170 | 5,748,900 | |
| $4.230 | +0.230 | +5.8% | $3.950 | $4.780 | $3.850 | 24,435,300 | |
| $4.000 | 0.000 | 0.0% | $4.000 | $4.120 | $3.945 | 1,606,900 | |
| $4.000 | -0.130 | -3.1% | $4.130 | $4.350 | $4.000 | 1,706,900 | |
| $4.130 | -0.040 | -1.0% | $4.120 | $4.160 | $3.905 | 2,696,100 | |
| $4.170 | +0.210 | +5.3% | $3.960 | $4.350 | $3.900 | 2,084,600 | |
| $3.960 | +0.030 | +0.8% | $3.970 | $4.055 | $3.820 | 1,427,200 | |
| $3.930 | -0.180 | -4.4% | $4.110 | $4.190 | $3.920 | 2,649,400 | |
| $4.110 | -0.030 | -0.7% | $4.210 | $4.360 | $4.075 | 2,953,800 | |
| $4.140 | -0.020 | -0.5% | $4.130 | $4.245 | $4.000 | 2,913,200 | |
| $4.160 | +0.160 | +4.0% | $4.040 | $4.230 | $3.980 | 3,325,600 | |
| $4.000 | -0.100 | -2.4% | $4.100 | $4.190 | $3.923 | 2,044,000 | |
| $4.100 | +0.060 | +1.5% | $4.030 | $4.190 | $3.920 | 1,465,000 | |
| $4.040 | -0.120 | -2.9% | $4.270 | $4.280 | $3.915 | 1,510,900 | |
| $4.160 | -0.170 | -3.9% | $4.320 | $4.320 | $3.840 | 3,433,200 | |
| $4.330 | -0.180 | -4.0% | $4.525 | $4.550 | $4.162 | 2,061,600 | |
| $4.510 | +0.010 | +0.2% | $4.560 | $4.620 | $4.450 | 2,150,200 | |
| $4.500 | +0.040 | +0.9% | $4.550 | $4.550 | $4.370 | 1,111,100 | |
| $4.460 | -0.110 | -2.4% | $4.500 | $4.608 | $4.400 | 1,657,100 | |
| $4.570 | -0.040 | -0.9% | $4.720 | $4.840 | $4.530 | 1,666,600 | |
| $4.610 | -0.320 | -6.5% | $4.940 | $4.980 | $4.584 | 1,269,700 | |
| $4.930 | -0.280 | -5.4% | $5.200 | $5.240 | $4.740 | 2,637,400 | |
| $5.210 | 0.000 | 0.0% | $5.210 | $5.360 | $5.150 | 1,039,100 | |
| $5.210 | -0.170 | -3.2% | $5.480 | $5.580 | $5.150 | 1,421,200 | |
| $5.380 | -0.330 | -5.8% | $5.600 | $5.740 | $5.365 | 1,150,900 | |
| $5.710 | -0.420 | -6.9% | $6.040 | $6.050 | $5.630 | 1,730,800 | |
| $6.130 | -0.100 | -1.6% | $6.230 | $6.230 | $5.900 | 1,617,100 | |
| $6.230 | +0.350 | +6.0% | $5.800 | $6.260 | $5.630 | 1,388,400 | |
| $5.880 | +0.210 | +3.7% | $5.690 | $5.940 | $5.500 | 1,773,100 | |
| $5.670 | +0.020 | +0.4% | $5.670 | $5.870 | $5.485 | 934,500 | |
| $5.650 | +0.110 | +2.0% | $5.520 | $5.680 | $5.390 | 1,096,200 | |
| $5.540 | -0.180 | -3.1% | $5.680 | $5.680 | $5.390 | 1,378,600 | |
| $5.720 | -0.130 | -2.2% | $5.880 | $5.890 | $5.490 | 1,892,700 | |
| $5.850 | -0.140 | -2.3% | $6.020 | $6.030 | $5.840 | 1,099,000 | |
| $5.990 | -0.330 | -5.2% | $6.130 | $6.300 | $5.980 | 1,794,500 | |
| $6.320 | +0.020 | +0.3% | $6.370 | $6.490 | $6.180 | 2,817,000 | |
| $6.300 | +0.450 | +7.7% | $5.850 | $7.060 | $5.619 | 8,341,800 | |
| $5.850 | +0.100 | +1.7% | $5.780 | $5.988 | $5.755 | 722,100 | |
| $5.750 | -0.090 | -1.5% | $5.810 | $5.810 | $5.540 | 796,900 | |
| $5.840 | +0.070 | +1.2% | $5.920 | $6.020 | $5.780 | 884,800 | |
| $5.770 | +0.090 | +1.6% | $5.620 | $5.910 | $5.620 | 909,300 |
- Ticker
- NASDAQ:ZURA
- Asset type
- Stock
- Sector
- Health care
- Industry
- Biotechnology
- Exchange
- NASDAQ
- Currency
- USD
What changed lately
Latest news release · Nov 9, 2026
Zura Bio Provides Clinical Update on Phase 2 TibuSHIELD Study of Tibulizumab (ZB-106) in Hidradenitis Suppurativa
Latest deck · Oct 27, 2026
Investor Presentation (October 2026)
Investor deck · 51 slides
Latest news
Zura Bio Provides Clinical Update on Phase 2 TibuSHIELD Study of Tibulizumab (ZB-106) in Hidradenitis Suppurativa
Nov 9, 2026
Closed $1.24 (-69.7%) on Nov 9, 2026
Zura Bio Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Oct 27, 2026
Closed $4.35 (+1.9%) on Oct 28, 2026
Zura Bio Reports Third Quarter 2026 Financial Results and Recent Corporate Updates
Oct 27, 2026
Closed $4.27 (+19.9%) on Oct 27, 2026
Zura Bio to Participate in the Cantor Global Healthcare Conference
Aug 31, 2026
Closed $5.65 (+2.0%) on Sep 1, 2026
Zura Bio Reports Second Quarter 2026 Financial Results and Recent Corporate Updates
Aug 11, 2026
Closed $5.56 (-1.2%) on Aug 11, 2026
Zura Bio Exceeds Enrollment Target in Both Hidradenitis Suppurativa (HS) & Systemic Sclerosis (SSc) Phase 2 Studies and Expands Tibulizumab Program
Jun 29, 2026
Closed $5.63 (+5.2%) on Jun 29, 2026
Zura Bio Expands Leadership Team with Appointment of Muzammil Mustufa as Chief Business Officer
May 13, 2026
Closed $4.80 (+1.1%) on May 13, 2026
Zura Bio Reports First Quarter 2026 Financial Results and Recent Corporate Updates
May 7, 2026
Closed $4.54 (-7.2%) on May 7, 2026
Zura Bio Reports Full Year 2025 Financial Results and Recent Corporate Updates
Mar 19, 2026
Closed $6.12 (+2.2%) on Mar 19, 2026
Financings
Public offering of class A ordinary shares and pre-funded warrants
Feb 27, 2026
Closed: US$144M raised · US$6.25 a share · Leerink Partners +3
Dealers: Leerink Partners (co-lead), Piper Sandler (co-lead), Cantor (co-lead), Wedbush PacGrow
Announced Feb 24, 2026 · Update Feb 25, 2026 · Closed Feb 27, 2026
Decks
Investor Presentation (October 2026)
Investor deck · 51 slides · Oct 27, 2026
Investor Presentation (August 2026)
Investor deck · 50 slides · Aug 11, 2026
Investor Presentation (August 2026)
Investor deck · 51 slides · August 2026
Investor Presentation (July 2026)
Investor deck · 31 slides · Jul 1, 2026
Zura Bio Limited on 6ix
- Sector
- Health care
- Industry
- Biotechnology
- News releases
- 19 in the last 12 months · 54 in all · newest Nov 9, 2026 · oldest 2023
- Decks
- 23 decks · latest Oct 27, 2026
Where Zura Bio Limited is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| NASDAQ:ZURA · Home listing · This page | NASDAQ | United States | USD |
| Frankfurt:94E | Frankfurt | Germany | EUR |
| Stuttgart:94E | Stuttgart | Germany | EUR |
| BOATS:ZURA | BOATS | United States | USD |
| Dusseldorf:94E | Dusseldorf | Germany | EUR |
| Tradegate:94E | Tradegate | Germany | EUR |
Log in to ask 6ix AI your own questions about Zura Bio Limited.